SavedAdd your journal

Journals / Nöropsikiyatri Arşivi / 2020 / Cilt: 57 - Sayı: 1

An Unusual Recurrence of Miller Fisher Syndrome: Three Times in Eight Years

Miller Fisher Sendromunun Alışılmadık Tekrarı: Sekiz Yılda Üç Kez

Belma DOĞAN GÜNGEN
Yeşim GÜZEY ARAS
Zeynep ÖZÖZEN AYAS
Pages
78–79
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is emphasized that MFS cases may occur a recurring pattern, and plasmaexchange should be definitely tried as a therapeutic approach when clinical deterioration occurs under intravenous immunoglobulin (IVIg) therapy

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Miller Fisher Syndrome (MFS) is an acute, autoimmune polyneuropathy usually associated with a good prognosis which is clinically characterized by ataxia, ophtalmoplegia, and areflexia.
📊
Key Findings & Data:In this article, we discussed a rare case of MFS and approach to the treatment that recurred 3 times within a period of 8 years.
💡
Conclusion & Impact:It is emphasized that MFS cases may occur a recurring pattern, and plasmaexchange should be definitely tried as a therapeutic approach when clinical deterioration occurs under intravenous immunoglobulin (IVIg) therapy
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Miller Fisher Syndrome (MFS) is an acute, autoimmune polyneuropathy usually associated with a good prognosis which is clinically characterized by ataxia, ophtalmoplegia, and areflexia. MFS has a monophasic course,double recurrence can be seen in rare cases. But three attacks are very rare. In this article, we discussed a rare case of MFS and approach to the treatment that recurred 3 times within a period of 8 years. It is emphasized that MFS cases may occur a recurring pattern, and plasmaexchange should be definitely tried as a therapeutic approach when clinical deterioration occurs under intravenous immunoglobulin (IVIg) therapy

Özet

Miller Fisher Sendromu (MFS) akut, genellikle iyi prognoz ile ilişkili otoimmün bir polinöropati olup, klinik olarak ataksi, oftalmopleji ve arefleksi ile karakterizedir. MFS monofazik seyirlidir, ikinci tekrar nadir vakalarda görülmektedir. Ancak, üç atak oldukça nadirdir. Bu yazıda, sekiz yıllık periotta üç kez tekrarlayan nadir bir MFS olgusu ve tedaviye yaklaşım tartışılmıştır. MFS’lu olguların tekrarlayıcı bir patern gösterebileceği ve plazma değişiminin intravenöz immünglobulin (IVIg) tedavisi altında klinik kötüleşmesi olan hastalarda tedavi edici bir yaklaşım olarak denenebileceği vurgulanmıştır

🔖

Cite This Article

GÜNGEN, B. D., ARAS, Y. G., AYAS, Z. Ö. (2022). An Unusual Recurrence of Miller Fisher Syndrome: Three Times in Eight Years. Nöropsikiyatri Arşivi, Cilt: 57 - Sayı: 1, 78–79. https://ajindex.com/articles/584646

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Fisher M. An unusual variant of acute immune polyneuritis (syndrome of ophtalmoplegia, ataxia, andareflexia). N Engl J Med 1956;255:57–65. [CrossRef] 2. Hiew FL, Ramlan R, Viswanathan S, Puvanarajah S. Guillain-Barre Syndrome, variants&forms fruste: Reclassification with new criteria. Clin Neurol Neurosurg 2017;158:114–118. [CrossRef] 3. Kuwabara S. Pathophysiology of Ataxia in Fisher Syndrome. Brain Nerve 2016;68:1411–1414. [CrossRef] 4. Bukhari S, Taboada J. A case of Miller Fisher Syndrome and Literature Review. Cureus 2017;9:e1048. [CrossRef] 5. Ishii J, Yuki, N, Kawamoto M, Yoshimura H, Kusunoki S, Kohara N. Recurrent Guillain-Barre syndrome, Miller Fisher syndrome and Bickerstaff brainstem encephalitis. J Neurol Sci 2016;364:59–64. [CrossRef] 6. Gür S, Tunçer ÖG, Tolun R, Altındağ E, Krespi Y. Recurrent Miller-Fisher Syndrome: A case report. Arch Neuropsychiatry 2011;48:281–284. [CrossRef] 7. Riche G, Caudie C, Vial C, Bourrat C. Recurrent Miller Fisher syndrome and anti-GQ1b antibodies. Rev Med Interne 1998;19:192–195. [CrossRef] 8. Chida K, Nomura H, Konno H, Takase S, Itoyama Y. Recurrent Miller Fisher syndrome: clinical and laboratory features and HLA antigens. J Neurol Sci 1999;165:139–143. [CrossRef] 9. Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, Honnorat J, Smitt PS, Vedeler Ch, Verschuuren JJ, Vincent A, Voltz R. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004;75:1135–1140. [CrossRef] 10. Mori M, Kuwabara S, Fukutake T, Hattori T. Intravenous immunglobulin theraphy for Miller Fisher syndrome. Neurology 2007;68:1144–1146. [CrossRef]